|
The
Family Studies of Schizophrenia at the University of
Pittsburgh Dr. Vishwajit Nimgaonkar, Professor
of Psychiatry and Human Genetics at the University of
Pittsburgh, is inviting volunteers to participate in our
research studies of schizophrenia and related illnesses.
Funded by the National Institute of Mental Health,
the studies extend Dr. Nimgaonkar’s efforts to identify
the genetic and environmental causes of these severe brain
disorders. This
multinational research is being conducted in collaboration
with researchers at the University of Pennsylvania, the
University of Alabama-Birmingham, The Southwest Foundation
for Biomedical Research, researchers in New Delhi, India,
and scientists in the United Kingdom.
These research studies are seeking families with an
individual diagnosed with schizophrenia, schizoaffective
disorder, or bipolar disorder.
Please contact us for more information if you feel
your family may be able to help in our research effort. A
Message to our Past Families: How has your contribution
helped? We would like to use this section to address recent questions by our most valuable resource in research, our participants. “Why hasn’t there been a gene discovered for
schizophrenia”? There has been enormous progress in the
field of genetics in recent years, and some of these
advances have been well publicized in the media.
However, progress in psychiatric genetics research has not
been as marked, and we certainly wish discoveries were being
made more rapidly. One of the main reasons for the
pace of psychiatric genetics research is the complexity of
the disorders being studied, especially with reference to
schizophrenia. As families can attest, schizophrenia
is an extraordinarily complex disease that may manifest in
many different ways. While illnesses such as
Huntington’s Disease and Cystic Fibrosis are caused by
defects in a single gene, otherwise known as a monogenic
disorder, it is believed that schizophrenia is caused by a
number of different genetic changes that may have a
cumulative effect on the disorder. Thus, the genetic
changes that contribute to the development of schizophrenia
in one individual may be different than those that lead to
the disease in another individual. This is known as
heterogeneity and it is a major hurdle in schizophrenia
genetics studies. This problem is compounded by the
strong environmental influences of many mental illnesses,
which again make contributing genetic factors more difficult
to isolate. Thus, while there have been a number of findings
in the field of schizophrenia genetics, these findings have
generally been difficult to replicate in multiple
populations. “Has
any progress been made in the field and at the University of
Pittsburgh?” Yes, there have been a number of
exciting discoveries recently in laboratories all over the
world. Different investigators have reported on
possible disease causing genes on several chromosomes,
including chromosomes 1, 6, 8, 13, and 22. However,
these research studies have been done on different
populations throughout the world and many of them must be
replicated before they can be considered possible
susceptibility genes. One discovery in the field by
Dr. Nimgaonkar and colleagues here at the University of
Pittsburgh was the report of a gene that may contribute to
schizophrenia on chromosome 1. The possible role of this
gene in mental illness via altered expression of dopamine
levels in the brain has been encouraging and is currently
being tested in other populations. As always, we will
report these results in this newsletter and scientific
articles. In summary, we realize the lack of
definitive results from research into psychiatric genetics
and schizophrenia has been very frustrating as our
participants and families are eagerly awaiting a
breakthrough in the field. However, we would like you
to know that progress is being made every day.
Further, thanks to your contributions Dr. Nimgaonkar and
colleagues here at the University of Pittsburgh remain on
the forefront of this research. As stated
earlier, the contribution of time and information from our
families remains our most valuable resource. As
always, we ask that families continue to spread information
about our studies to anyone they feel may qualify to
participate in our research. Our
African-American study has begun! We recently began our newest study
investigating inheritance of schizophrenia and related
illnesses in African American families. This
study seeks to identify genes that play a role in the
inheritance of schizophrenia. This research is
significant because it extends our studies to a minority
population, African Americans. To date, the great
majority of our participants have been European Americans.
This new study will help to ensure that the results we
obtain will be relevant to different racial and ethnic
groups. We are seeking African American families with
at least one individual diagnosed with schizophrenia or
schizoaffective disorder as well as their family members.
Subjects will be asked to undergo the same procedures as our
other studies and all subjects will be reimbursed $100 for
participation.
PLEASE
CONTACT US FOR MORE INFORMATION IF YOUR FAMILY WOULD LIKE TO
HELP!!! Join the growing number of families who have helped worldwide!
As the above table shows, our combined research staff in
the United States and New Delhi, India, has completed work
with a total of 1007 families who have generously
volunteered their time to promote our understanding of
schizophrenia & bipolar disorder. Worldwide,
schizophrenia and bipolar disorder each affect an average of
1% of the population of any given country or culture.
Appropriately, the effort to defeat these illnesses has
become international in scope. If you can count
yourself among the families who have volunteered, we cannot
thank you enough! To provide even greater power to
our laboratory work, we are striving to include several
hundred more families into our study. We are always
happy to hear from new families interested in participating.
If you would like to participate, or learn more about our
study, please call us toll free at 1 - 877 - 363 - 5895. Our Research Staff Continues to Expand! To meet the
growing needs of our expanding research studies, we have
hired a number of new staff members to bring unique
expertise to our research and fulfill the needs of such a
large project. They include: Michael Talkowski,
Recruitment
Coordinator, Pittsburgh Travis Logue,
Laboratory Technician,
Pittsburgh
Fran Lokar,
Recruiter, Pittsburgh Todd Schoeni,
Interviewer,
Pittsburgh Frank Fleischer, Recruiter, Ohio Kay Borneman,
Recruiter.
Sourthwestern Ohio and surrounding areas. Angela
Russo, Interviewer, Pittsburgh Rose Jarosz,
Project Coordinator for Bipolar Disorder, Pittsburgh Muhdulika Dayal,
Data Manager, Pittsburgh Monisha Tarneja,
Project Coordinator for Indo-US Psychiatric Genetics,
Pittsburgh A summary of our recent lab work and other studies By Vishwajit L. Nimgaonkar, MD, PhD Work
in Pittsburgh: We
are continuing exciting work to find genes which may
contribute to the causation of schizophrenia.
Dr Mansour Hader is investigating the possible role
of genes regulating circadian function in the causation of
bipolar disorder. Dr
Jung Jin Kim is investigating the role of genes located on
chromosome 6 in the causation of schizophrenia.
Finally, Dr K V Chowdari, our Laboratory Director, is
working with colleagues in the Department of Neuroscience to
examine variations in certain brain expressed genes.
These genes were identified earlier by our colleagues
(Drs D Lewis, K Mirnics, P Levitt) as being of potential
importance from their studies involving post-mortem brain.
In other words, our colleagues found that the levels
of proteins that were encoded by these genes were different
among brains of patients compared with unaffected
individuals. We
have recently received funds to investigate the possible
role of dopamine related genes in the causation of
schizophrenia, using comprehensive analyses. Work in India: We have recently received funds from the National Institute of Mental Health to continue our research in India for five more years. A separate five-year grant from the Fogarty International Center, a branch of the National Institute of Health, will enable us to train psychiatrists and ethicists from India. Thus, we hope to establish a tradition of psychiatric genetic research in India. www.pitt.edu/~nimga/ (schizophrenia) / www.wpic.pitt.edu/research/neurogen/ (bipolar disorder) Contact Dr. Nimgaonkar directly at (412) 624-0823 or email nimga+@pitt.edu |
|||||||||||||||||||||||||||||